Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Adaptive Immune System
18%
B Cell
26%
B-Cell Receptor
18%
Chemokine
17%
Chemokine Receptor CXCR4
12%
Colitis
15%
Crohn's Disease
59%
CXCR4
25%
CXCR7
18%
Cytokine
13%
Enteritis
18%
Enterocolitis
18%
Glycoprotein
37%
Homeostasis
19%
Hypha
9%
Immune Dysregulation
9%
Immune Repertoire
17%
Immune System
21%
Immunocompetent Cell
13%
Immunodeficiency
19%
Immunomodulating Drugs
9%
Infection
18%
Infectious Disease
20%
Inflammation
33%
Inflammatory Bowel Disease
100%
Innate Immune System
15%
Interleukin 10
20%
Interleukin-10 Receptor
18%
Intestine
10%
Macrophage
12%
Macrophage Function
9%
Mass Cytometry
11%
Maturation
9%
Memory T Cell
12%
Metabolite
9%
Microbiome
14%
Monocyte
30%
Myosin
9%
Next Generation Sequencing
24%
Notch
9%
Regulatory T Cell
17%
Screening Test
9%
Sialylation
9%
Small Intestine
9%
T Cell
64%
T Cell Activation
12%
T Cell Receptor
45%
TNF Inhibitor
10%
Tumor Necrosis Factor Alpha
11%
Ulcerative Colitis
41%
Keyphrases
Adaptive Immune Response
14%
C-X-C Chemokine Receptor Type 4 (CXCR4)
18%
Chemokine Ligand 12 (CXCL12)
18%
Chronic Pouchitis
10%
Colitis
11%
Control Subjects
17%
Crohn's Disease
74%
CXCR7
18%
Dilated Cardiomyopathy
9%
Eosinophilic Diseases
9%
Experimental Myocarditis
9%
Expression Pattern
9%
Glycoprotein 2
37%
Homeostasis
10%
Host-commensal
9%
IL-10 Receptor
11%
Immune Dysregulation
10%
Infantile Onset
27%
Inflammation
26%
Inflammatory Bowel Disease
61%
Innate Immune Response
15%
Interleukin-10
20%
Interleukin-10 Receptor
18%
Intestinal Epithelial Cells
10%
Intestinal Inflammation
18%
Memory T Cells
9%
Metabolomics
9%
Monocyte Function
9%
Monocytes
21%
Myosin 1C
9%
Necrotizing Enterocolitis
9%
Neutropenia
9%
Normal Response
9%
Pediatric Patients
13%
Pediatric Ulcerative Colitis
9%
Pouch
13%
Premature Infant
9%
Recurrent Infections
10%
Severe Combined Immunodeficiency
9%
Specific Biomarkers
9%
T Cell Receptor
12%
T Cells
25%
T Helper 17 Cells (Th17)
9%
T-cell Receptor Repertoire
16%
Therapeutic Interventions
10%
Thiopurines
9%
Ulcerative Colitis
28%
Ulcerative Colitis Patient
17%
Vedolizumab
9%
Very Early-onset Inflammatory Bowel Disease
13%